Abacavir And Lamivudine 68180-0288
Product NDC
68180-0288- Manufacturer
- Lupin Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- March 28, 2017
- Listing Expires
- December 31, 2026
- Application
- ANDA204990
Need to source Abacavir And Lamivudine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abacavir Sulfate | 600 mg/1 |
| Lamivudine | 300 mg/1 |
Drug Class
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]Cytochrome P450 1A1 Inhibitors [MoA]